Diagnosis and treatment of dementia: Introduction - Introducing a series based on the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia

CMAJ. Canadian Medical Association Journal

Volumn 178, Issue 3, 2008, Pages 316-321

  Chertkow, Howard ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CHOLINESTERASE INHIBITOR; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ALZHEIMER DISEASE; CANADA; CLINICAL FEATURE; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEMENTIA; DIAGNOSTIC VALUE; FRONTOTEMPORAL DEMENTIA; HUMAN; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; NEUROIMAGING; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 38949108762     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.070795     Document Type: Note

References (22)

1. Canadian Study of Health and Aging: Risk factors for Alzheimer's disease in Canada. Neurology 1994;44:2073-80.
2. The incidence of dementia in Canada. The Canadian Study of Health and Aging Working Group. Neurology 2000;55:66-73.
3. Canadian study of health and aging: study methods and prevalence of dementia. CMAJ 1994;150:899-913.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington: The Association; 1994.
5. Wells CE. Differential diagnosis of Alzheimer's dementia: affective disorder. In: Reisberg B, ed. Alzheimer's Disease: The Standard Reference. New York: Free Press; 1983. p.193-7.
6. Feldman H, Levy AR, Hsiung GY, et al. A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results. Neuroepidemiology 2003;22:265-74.
7. Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997;277:813-7.
8. Hux MJ, O'Brien BJ, Iskedjian M, et al. Relation between severity of Alzheimer's disease and costs of caring. CMAJ 1998;159:457-65.
9. Patterson CJ, Gauthier S, Bergman H, et al. The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. CMAJ 1999;160(Suppl):S1-15.
10. Patterson CJ, Gauthier S, Bergman H, et al. Canadian Consensus Conference on Dementia: a physician's guide to using the recommendations. CMAJ 1999;160:1738-42.
11. Jack CR Jr, Petersen RC, Xu Y, et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 2000;55:484-9.
12. Klunk WE, Price JC, DeKosky ST, et al. The applications of amyloid-imaging to the diagnosis and treatment of Alzheimer's disease. Alzheimers Demen 2005;1(Suppl):5.
13. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346:476-83.
14. Rogaeva E, Meng Y, Lee JH, et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 2007;39:168-77.
15. Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006;442:916-9.
16. Mackenzie IR, Baker M, West G, et al. A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. Brain 2006;129:853-67.
17. Areosa SA, Sherriff F, McShane R. Memantine for dementia. Cochrane Database Systematic Reviews 2005 Jul 20; (3): CD003154.
18. The Appraisal of Guidelines Research and Evaluation (AGREE) Collaboration. The AGREE Instrument. London (UK): The Collaboration; 2001. Available: www.agreecollaboration.org/pdf/agreeinstrumentfinal.pdf (accessed 2007 Dec 20).
19. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
20. Natural Standard. Explanation of Columns in Natural Standard Evidence Table. Cambridge (MA): The Standard. www.naturalstandard.com/ explanation_columns.html (accessed 2007 Dec 20).
21. Woolf SH, Battista RN, Anderson GM, et al. Assessing the clinical effectiveness of preventive maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian Task Force on the Periodic Health Examination. J Clin Epidemiol 1990;43:891-905.
22. Patterson C, Gauthier S, Bergman H, et al. The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. Can J Neurol Sci 2001;28(Suppl 1):S3-16.